Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05518305 · ClinicalTrials.gov registry record
Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
A clinical trial of Stroke and Ischemic Stroke, sponsored by University of California, Los Angeles.
- Recruiting
- Registry status
- 250
- Enrollment target
- 1
- Study location
NCT05518305: Recruiting study of Stroke and Ischemic Stroke, sponsored by University of California, Los Angeles.
NCT05518305 is a study of Stroke and Ischemic Stroke that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 250 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05518305, a study of Stroke and Ischemic Stroke, is actively recruiting participants, sponsored by University of California, Los Angeles.
- RECRUITING
- Registry status
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
An observational study to determine if individuals with increased platelet FcyRIIa will have a higher risk of ischemic events.
Primary Outcome
The investigators hypothesize that increased platelet FcγRIIa will be associated with a greater risk of ischemic events. Platelet FcγRIIa expression will be quantified in 250 subjects enrolled at 6 sites with stroke or TIA due to 50-99% ICAD to determine impact of FcγRIIa on 1-year risk of recurrent stroke, including clinical events and serial MRI.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Medical Imaging
Study Locations (1)
California
- Ronald Reagan UCLA Medical Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2022-09-30 |
| Est. Completion | 2027-09-30 |
What NCT05518305 shows while recruiting
NCT05518305 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (98% lower).
The record links to 4 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Medical Imaging is the first listed.
NCT05518305 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05518305 about?
NCT05518305 is a clinical study titled "Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis". An observational study to determine if individuals with increased platelet FcyRIIa will have a higher risk of ischemic events.
What is the current status of trial NCT05518305?
This trial is currently recruiting. The enrollment target is 250 participants. The study started on 2022-09-30. Estimated completion is 2027-09-30.
What conditions does trial NCT05518305 study?
This clinical trial studies the following conditions: Stroke, Ischemic Stroke, TIA, Ischemic.
What interventions are being tested in trial NCT05518305?
The interventions under investigation include: Medical Imaging (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05518305?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05518305 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05518305's enrollment target sits among peer trials
250 86th of 454 higher than 366 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The SLEEPR Study: SLEep Effects on Post-stroke Rehabilitation
RECRUITING
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Genetic and Environmental Risk Factors for Hemorrhagic Stroke
RECRUITING
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI